White label – Pompe disease - ClinicalTrials.eu

Study of ziltivekimab compared to placebo in patients with acute heart attack to evaluate its effects on coronary artery plaque reduction

Recruiting

3 1
Investigated Drugs:
- Ziltivekimab
Study of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib

Recruiting

3 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
- Breast cancer
Investigated Drugs:
- Ribociclib
Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

Recruiting

3 1 1
Investigated Diseases:
- Bipolar I disorder
Investigated Drugs:
- Trospium Chloride
- Xanomeline Tartrate
+5
Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

Recruiting

3 1 1
Investigated Drugs:
- Saccharomyces Boulardii Cncm I-745 Lyophilized
- Loperamide Hydrochloride
Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
+8
Study of trospium chloride and xanomeline tartrate (KarXT) for treating manic episodes in adults with bipolar I disorder

Recruiting

3 1
Investigated Drugs:
- Trospium Chloride
- Xanomeline Tartrate
Study of hypertonic saline solution and mannitol to improve recovery in patients with traumatic brain injury and high risk of intracranial hypertension

Recruiting

3 1 1 1
Investigated Diseases:
- Craniocerebral injury
Investigated Drugs:
- Mannitol
- Sodium Chloride
Study of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy

Recruiting

4 1 1 1
Investigated Diseases:
- Cholangiocarcinoma
Investigated Drugs:
- Ivosidenib
Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

Recruiting

3 1 1 1
Investigated Drugs:
- Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

Recruiting

3 1 1 1
Investigated Drugs:

powered by

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes